[go: up one dir, main page]

AR094413A1 - Composiciones nutricionales conteniendo un componente neurológico y usos de las mismas - Google Patents

Composiciones nutricionales conteniendo un componente neurológico y usos de las mismas

Info

Publication number
AR094413A1
AR094413A1 ARP140100093A ARP140100093A AR094413A1 AR 094413 A1 AR094413 A1 AR 094413A1 AR P140100093 A ARP140100093 A AR P140100093A AR P140100093 A ARP140100093 A AR P140100093A AR 094413 A1 AR094413 A1 AR 094413A1
Authority
AR
Argentina
Prior art keywords
nutritional compositions
neurological component
neurological
same
compositions containing
Prior art date
Application number
ARP140100093A
Other languages
English (en)
Inventor
Kuang Chenzhong
Xiao Yan
K Poels Eduard
Jouni Zeina
Hondmann Dirk
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of AR094413A1 publication Critical patent/AR094413A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente divulgación se refiere a composiciones nutricionales que comprenden un componente neurológico, en donde, el componente neurológico puede promover el desarrollo del sistema nervioso y el cerebro y además puede proporcionar reparación y protección neurológica; el componente neurológico puede incluir fosfatidil-etanolamina, esfingomielina, citidina difosfato-colina, ceramida, uridina, por lo menos un gangliósido, y mezcla de los mismos; la divulgación además se refiere a métodos para promover la salud del sistema nervioso y el cerebro al proveer dichas composiciones nutricionales a sujetos destinatarios, que incluyen a pacientes pediátricos.
ARP140100093A 2013-01-11 2014-01-10 Composiciones nutricionales conteniendo un componente neurológico y usos de las mismas AR094413A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/739,787 US20140199265A1 (en) 2013-01-11 2013-01-11 Nutritional compositions containing a neurologic component and uses thereof

Publications (1)

Publication Number Publication Date
AR094413A1 true AR094413A1 (es) 2015-07-29

Family

ID=49887324

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100093A AR094413A1 (es) 2013-01-11 2014-01-10 Composiciones nutricionales conteniendo un componente neurológico y usos de las mismas

Country Status (16)

Country Link
US (1) US20140199265A1 (es)
EP (1) EP2943079A1 (es)
CN (1) CN104883909A (es)
AR (1) AR094413A1 (es)
AU (1) AU2013372898B2 (es)
BR (1) BR112015016358A2 (es)
CA (1) CA2912246A1 (es)
HK (1) HK1214090A1 (es)
IN (1) IN2015DN04207A (es)
MX (1) MX2015008585A (es)
PE (1) PE20151771A1 (es)
PH (1) PH12015501504A1 (es)
RU (1) RU2015120263A (es)
SG (1) SG11201503682VA (es)
TW (1) TW201440669A (es)
WO (1) WO2014109862A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9980506B2 (en) 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9661874B2 (en) 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9241923B2 (en) 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9226914B2 (en) 2013-07-16 2016-01-05 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US10028519B2 (en) * 2014-03-05 2018-07-24 Mead Johnson Nutrition Company Nutritional compositions containing ceramide and uses thereof
US20150305359A1 (en) * 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
US20160095339A1 (en) * 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
RU2706963C2 (ru) * 2014-11-26 2019-11-21 Абботт Лаборэтриз Молочная смесь, содержащая олигосахариды грудного молока, полиненасыщенные жирные кислоты, нуклеотиды и лютеин
US10617701B2 (en) * 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US20170006897A1 (en) * 2015-07-10 2017-01-12 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10582714B2 (en) * 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
PH12021551548A1 (en) * 2015-12-14 2022-07-18 Socia‰Ta‰ Des Produits Nestla‰ S A Nutritional composition and infant formula for promoting myelination of the brain
WO2017102720A1 (en) * 2015-12-14 2017-06-22 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
CN105638906A (zh) * 2016-01-11 2016-06-08 东北农业大学 一种满足婴儿的脂质个性化营养需求的婴儿配方奶粉
WO2017176109A1 (en) 2016-04-04 2017-10-12 N.V. Nutricia Method for reducing or preventing global developmental delay in children
JP2020518232A (ja) * 2017-05-04 2020-06-25 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 神経発達を促進する食品組成物、ならびにそれに関連するキット、システム、および方法
JP7150281B2 (ja) * 2017-07-20 2022-10-11 国立研究開発法人理化学研究所 連続的な上皮を含む網膜組織の成熟化方法
CA3076188A1 (en) * 2017-09-14 2019-04-18 Lewis KILMAN CLARKE Neupanex.rtm.: neuroprotective, neuroregenerational & neurogenesis supp orting supplement combination
US11357803B2 (en) * 2017-09-22 2022-06-14 Iowa State University Research Foundation, Inc. Probiotic compositions for production of dopamine
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
RU2758128C1 (ru) 2017-12-29 2021-10-26 Крафт Фудс Груп Брэндс Ллк Улучшенная устойчивость к окислению эмульсий типа "масло в воде" при помощи натуральных стабилизаторов
IT202100022427A1 (it) * 2021-08-27 2023-02-27 Buona S P A Soc Benefit Composizione per la maturazione del sistema nervoso centrale
CN117045760B (zh) * 2023-07-20 2025-03-28 深圳市金枫生物医药科技有限公司 一种神经修复组合物及其制备方法和应用
WO2025143715A1 (ko) * 2023-12-26 2025-07-03 주식회사 비케이바이오 인지질 혼합물, 중성지질 및 스핀고리피드를 포함하는 인지기능 개선 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143234B2 (en) * 1998-07-31 2012-03-27 Massachusetts Institute Of Technology Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
US20050013884A1 (en) * 2003-07-16 2005-01-20 Rennels M. Scott Compositions and methods for treating heart disease
CA2543626C (en) * 2003-10-24 2013-08-27 N.V. Nutricia Synbiotic composition for infants
IN2012DN02664A (es) * 2004-10-12 2015-09-11 Fonterra Co Operative Group
AU2012203650B2 (en) * 2005-05-23 2014-09-18 Massachusetts Institute Of Technology Compositions containing PUFA and methods of use thereof
PT1800675E (pt) * 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
US20130172286A1 (en) * 2010-03-31 2013-07-04 Vegenat, S.A. Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma

Also Published As

Publication number Publication date
WO2014109862A1 (en) 2014-07-17
MX2015008585A (es) 2015-09-04
IN2015DN04207A (es) 2015-10-16
RU2015120263A (ru) 2017-02-16
CA2912246A1 (en) 2014-07-17
PH12015501504A1 (en) 2015-09-28
SG11201503682VA (en) 2015-06-29
BR112015016358A2 (pt) 2017-07-11
TW201440669A (zh) 2014-11-01
AU2013372898B2 (en) 2016-12-08
US20140199265A1 (en) 2014-07-17
AU2013372898A1 (en) 2015-05-28
EP2943079A1 (en) 2015-11-18
HK1214090A1 (zh) 2016-07-22
PE20151771A1 (es) 2015-12-02
CN104883909A (zh) 2015-09-02

Similar Documents

Publication Publication Date Title
AR094413A1 (es) Composiciones nutricionales conteniendo un componente neurológico y usos de las mismas
CU20190101A7 (es) Imidazopirimidinas diazabicíclicas sustituidas
UY35427A (es) Compuestos y sus usos en la modulación de la hemoglobina
UY35425A (es) Compuestos y sus usos en la modulación de la hemoglobina
UY35472A (es) Compuestos y sus usos en la modulacion de la hemoglobina
UY35426A (es) Compuestos y sus usos en la modulación de la hemoglobina
SV2015005066A (es) Compuestos de biaril-amida como inhibidores de cinasa
NI201500140A (es) Compuestos y composiciones terapéuticos
UY32923A (es) Compuestos policíclicos como antagonistas del receptor de ácido lisofosfatídico
MX2015012456A (es) Compuestos heterociclicos y usos de los mismos.
MX2016004340A (es) Compuestos heterociclicos y usos de los mismos.
DOP2016000144A (es) Moduladores de tetrahidropiridopirazinas de gpr6
UY32092A (es) Nuevos compuestos para el tratamiento de trastornos del snc
CU20170160A7 (es) Derivadosde fenil-tieno(2,3-d)pirimidina- hidroxi-ésteres, un proceso para su preparación y composiciones farmacéuticas que lo contienen
MX2013012896A (es) Compuestos novedosos como moduladores de proteina cinasas.
MX2016014308A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7.
GT201400222A (es) Agentes para tratar trastornos que implican la modulación de receptores de rianodina
MX2016003486A (es) Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades.
ECSP14008757A (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CL2015002222A1 (es) Compuestos de azabencimidazol como inhibidores de isoenzimas pde4 para el tratamiento del snc y otros trastornos.
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
CL2014003130A1 (es) Compuestos derivados de n-piridinil amidas ciclicas,inhibidores de quinasas pim; composicion farmaceutica que los comprende; combinacion farmaceutica; metodo para tratar enfermedades tales como canceres o un trastorno autoinmune.
NI201600014A (es) Compuestos y composiciones como inhibidores de la mek.
UY35711A (es) Bis-amidopiridinas como moduladores de la actividad de iap y sus usos como miméticos de smac
NI202000029A (es) Amidas de imidazopiridina sustituidas y su uso

Legal Events

Date Code Title Description
FB Suspension of granting procedure